Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Weller

EANO Guideline for the Diagnosis and Treatment of Anaplastic Gliomas and Glioblastoma

The Lancet Oncology

Oncology

2014

English

Epilepsy Meets Cancer: When, Why, and What to Do About It?

The Lancet Oncology

Oncology

2012

English

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years Ahead of Initial Diagnosis

English

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses

Journal of Clinical Oncology

English

Long-Term Analysis of the NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide.

Journal of Clinical Oncology

English

cIMPACT-NOW Update 3: Recommended Diagnostic Criteria for “Diffuse Astrocytic Glioma, IDH-wildtype, With Molecular Features of Glioblastoma, WHO Grade IV”

Acta Neuropathologica

Forensic Medicine

Molecular Neuroscience

English

Rare ADAR and RNASEH2B Variants and a Type I Interferon Signature in Glioma and Prostate Carcinoma Risk and Tumorigenesis

Acta Neuropathologica

Forensic Medicine

Molecular Neuroscience

English

ATRX and IDH1-R132H Immunohistochemistry With Subsequent Copy Number Analysis and IDH Sequencing as a Basis for an “Integrated” Diagnostic Approach for Adult Astrocytoma, Oligodendroglioma and Glioblastoma

Acta Neuropathologica

Forensic Medicine

Molecular Neuroscience

English

Distribution of TERT Promoter Mutations in Pediatric and Adult Tumors of the Nervous System

Acta Neuropathologica

Forensic Medicine

Molecular Neuroscience

English

MGMT Promoter Methylation Cutoff With Safety Margin for Selecting Glioblastoma Patients Into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.

Clinical Cancer Research

Cancer Research

Oncology

2018

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Michael Weller

EANO Guideline for the Diagnosis and Treatment of Anaplastic Gliomas and Glioblastoma

Epilepsy Meets Cancer: When, Why, and What to Do About It?

Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years Ahead of Initial Diagnosis

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine–DNA Methyltransferase Biomarker Analyses

Long-Term Analysis of the NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide.

cIMPACT-NOW Update 3: Recommended Diagnostic Criteria for “Diffuse Astrocytic Glioma, IDH-wildtype, With Molecular Features of Glioblastoma, WHO Grade IV”

Rare ADAR and RNASEH2B Variants and a Type I Interferon Signature in Glioma and Prostate Carcinoma Risk and Tumorigenesis

ATRX and IDH1-R132H Immunohistochemistry With Subsequent Copy Number Analysis and IDH Sequencing as a Basis for an “Integrated” Diagnostic Approach for Adult Astrocytoma, Oligodendroglioma and Glioblastoma

Distribution of TERT Promoter Mutations in Pediatric and Adult Tumors of the Nervous System

MGMT Promoter Methylation Cutoff With Safety Margin for Selecting Glioblastoma Patients Into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.